|
Symbol
|
P322TQ | PMWLTQ | WEVLTQ | LTARCH | WXNLTQ | EOJRCH | XRYLTQ | RMABXV | YOTLTQ | RMBWDV | RMAVSV | Z0972Z | Z0974Z | Z0973Z | BTJBKB | ZPRLTQ | OCGRCH | HZJEFG | BZFBKB | ABOOSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Reverse Convertible |
|
Basiswert
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Geberit AG / Givaudan / Holcim/Amrize Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche AG / Swatch Group I / Swiss RE AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Lonza Group N / Roche GS / Sika AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG | ABB N / Kühne & Nagel Intl. AG / Roche GS / Swisscom N / Zurich Insurance Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
23.12.2025 | 09.02.2026 | 31.03.2028 | 24.09.2027 | 30.06.2028 | 14.01.2026 | 22.09.2028 | 12.10.2026 | 24.11.2027 | 27.07.2026 | 23.02.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 08.04.2027 | 23.04.2027 | 26.04.2027 | 02.11.2026 | 12.07.2027 | 05.07.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
66.90 | 56.45 | 71.27 | 401.50 | 58.95 | 287.84 | 160.62 | 182.96 | 178.20 | 63.33 | 47.42 | 22.9033 | 22.9279 | 22.9033 | 68.75 | 63.975 | 58.5776 | 182.298 | 183.056 | 177.072 |
|
Maximal- rendite p.a. |
133.86% | - | 5.10% | - | 6.34% | -5.18% | 9.50% | 9.72% | 6.02% | 4.59% | 79.19% | 3.93% | 7.71% | 6.02% | 3.65% | 3.06% | 4.19% | - | 12.80% | 12.09% |
| Geld | - | 95.99 | 100.69 | - | 94.91 | 100.78 | 87.12 | 95.90 | 96.22 | 100.00 | 79.00 | - | - | - | 100.41 | 103.42 | - | 86.68 | 91.72 | 88.00 |
| Brief | - | - | 101.50 | - | 95.71 | 101.59 | 87.92 | 96.70 | 97.02 | 101.00 | 86.00 | - | - | - | 101.22 | 104.25 | - | - | 92.52 | - |